Scientists and clinicians working together to beat cancer.
The Edinburgh Cancer Research is a part of the Institute of Genetics and Cancer (IGC; formerly the IGMM - Institute of Genetics and Molecular Medicine), however, in addition to scientists based at the IGC, our cancer research is carried out at other University of Edinburgh sites (our affiliates) or NHS Lothian locations.
A broad spectrum of tumor types are studied by our investigators and we aspire to be world class in key themes, bringing innovation and unique twists to basic cancer science, drug development and clinical translation.
Some areas studied by our researchers include:
- The state of the host: lifestyle, risk and prevention
- Stem cells and the cancer niche
- Signal transduction and biological mechanisms
- Phenomics Drug Discovery, incorporating advanced imaging, pathway profiling and novel informatics solutions
- Stratification for therapy
Clinical/translational emphasis is largely in colorectal cancer, women’s cancers (breast, ovarian and endometrial), and more recently in brain cancer, but we have also initiated new research programmes in three new cancer types; sarcoma, renal cancer and intrahepatic cholangiocarcinoma, a poorly researched cancer of unmet need.